Terms: = Head and neck cancer AND CEACAM5, CEA AND Staging
41 results:
1. Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
Deandrea M; Piticchio T; Mormile A; Retta F; Canale G; Caracciolo A; Daniele L; Trimboli P
Endocr J; 2023 Nov; 70(11):1061-1067. PubMed ID: 37690841
[TBL] [Abstract] [Full Text] [Related]
2. [Value of Baseline Calcitonin for Differential Diagnosis of Medullary Thyroid cancer].
Liu QH; Nie X; He Y; Yin MT; Li GX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):432-438. PubMed ID: 36949711
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of HSP90α and related markers in lung cancer.
Yuan Z; Wang L; Hong S; Shi C; Yuan B
J Clin Lab Anal; 2022 Jun; 36(6):e24462. PubMed ID: 35522136
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
Asa S; Sonmezoglu K; Uslu-Besli L; Sahin OE; Karayel E; Pehlivanoglu H; Sager S; Kabasakal L; Ocak M; Sayman HB
Ann Nucl Med; 2021 Aug; 35(8):900-915. PubMed ID: 33993425
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic value of [
Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
[TBL] [Abstract] [Full Text] [Related]
6. An Overview of Medullary Thyroid cancer Cases Treated at Kuwait cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract] [Full Text] [Related]
7. Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M; Trocchianesi S; Besharat ZM; Po A; Ferretti E
Pharmacol Ther; 2021 Mar; 219():107708. PubMed ID: 33091426
[TBL] [Abstract] [Full Text] [Related]
8. [Imaging of medullary thyroid carcinoma].
Uhrig M; Delorme S
Radiologe; 2019 Nov; 59(11):992-1001. PubMed ID: 31367891
[TBL] [Abstract] [Full Text] [Related]
9. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
10. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract] [Full Text] [Related]
11. [The clinical signifinace of cea, Cyfra21-1 and SCC in laryngeal carcinoma's clinicopathological parameters].
Rao LH; Zhang L; Tian L; Yan JR; Xiang XY; Yu FB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(15):1182-1186. PubMed ID: 29798354
[No Abstract] [Full Text] [Related]
12. High cea levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.
Chen SW; Chen YK
World J Surg Oncol; 2017 Dec; 15(1):230. PubMed ID: 29284496
[TBL] [Abstract] [Full Text] [Related]
13. PET imaging for thyroid cancers: Current status and future directions.
Giraudet AL; Taïeb D
Ann Endocrinol (Paris); 2017 Feb; 78(1):38-42. PubMed ID: 27989550
[TBL] [Abstract] [Full Text] [Related]
14. Sclerosing odontogenic carcinoma presenting on the hard palate of a 43-year-old female: a case report.
Wood A; Young F; Morrison J; Conn BI
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e204-e208. PubMed ID: 27743835
[TBL] [Abstract] [Full Text] [Related]
15. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract] [Full Text] [Related]
16. Charting a course through the ceas: diagnosis and management of medullary thyroid cancer.
Rowe CW; Bendinelli C; McGrath S
Clin Endocrinol (Oxf); 2016 Sep; 85(3):340-3. PubMed ID: 27230389
[TBL] [Abstract] [Full Text] [Related]
17. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract] [Full Text] [Related]
18. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract] [Full Text] [Related]
19. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract] [Full Text] [Related]
20. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
[TBL] [Abstract] [Full Text] [Related]
[Next]
